Pharmaceutical regulation in Europe and its impact on corporate R&D

OBJECTIVES: Many European countries regulate the markets for prescription drugs in order to cope with rising health expenditures. On the other hand, regulation distorts incentives to invest in pharmaceutical R&D. This study aims at empirically assessing the impact of regulation on pharmaceutical...

Descripción completa

Detalles Bibliográficos
Autores principales: Eger, Stephan, Mahlich, Jörg C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502069/
https://www.ncbi.nlm.nih.gov/pubmed/26208924
http://dx.doi.org/10.1186/s13561-014-0023-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502069/
https://www.ncbi.nlm.nih.gov/pubmed/26208924
http://dx.doi.org/10.1186/s13561-014-0023-5

Ejemplares similares